BioMarin Pharmaceutical, Inc. (BMRN)

58.13 +0.98 (+1.71%) USD  |  NASDAQ  |  Feb 06, 16:00
58.14 +0.01 (+0.02%) After-Hours: 20:00
More

BioMarin Pharmaceutical Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
Gilead Sciences, Inc. Upgrade
AbbVie, Inc. Upgrade
Amgen, Inc. Upgrade